BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 26, 2001
View Archived Issues
Flamel Technologies completes controlled-release antibiotic study
Read More
Amgen submits supplemental application with EMEA for anemia product
Read More
Genzyme General highlights Q3 developments
Read More
Catalytic antioxidant AEOL-10150 protects hamsters against radiation-induced mucositis
Read More
Combination of CCI-779 and 5-FU/LV associated with significant toxicity in phase I study
Read More
European Generx trial approved and set to commence
Read More
Impact of addition of BMS-275291 to paclitaxel/carboplatin examined in phase II/III trial in NSCLC
Read More
Merck KGaA and Forest to comarket treatment for alcohol addiction in the U.S.
Read More
Antimicrotubule agent T-900607 well tolerated in ongoing phase I trial in advanced cancer patients
Read More
Novel platinum analogue shows evidence of activity, adequate safety in phase II cancer trials
Read More
Tissue engineering product to begin clinical trials in the U.S.
Read More
SU-5416 may be useful in certain patients with c-kit-positive AML, according to phase II data
Read More
Gilead licenses its SELEX technology to Archemix
Read More
NXY-059 may have advantages over current neuroprotectants for the treatment of stroke
Read More
Merger of Barr and Duramed finalized this week
Read More
Oxigene regains rights to anticancer combretastatins, ends development of declopramide
Read More
Novartis receives approvable letter for Diovan as treatment for heart failure
Read More
ACG news: pilot study of APC-2059 demonstrates safety and activity in ulcerative colitis
Read More
Second activated macrophage therapy trial initiated in Belgium
Read More
Novel protein identified at CuraGen shows promise in IBD
Read More
Pyrimidines inhibit CDKs and FAK according to recent AstraZeneca patent
Read More
New series synthesized at Bayer shows inhibitory activity against cGMP-PDE
Read More
Takeda discloses agents for inflammation, arthritis and bone disorders
Read More
Scios patents discoveries in the field of bradykinin antagonists
Read More
New chroman derivatives designed at Akzo Nobel with affinity for estrogen receptors
Read More